FDA Approves Daraxonrasib to Fight Pancreatic Cancer

The U.S. Food and Drug Administration has approved daraxonrasib, a twice-daily oral medication designed to combat advanced pancreatic cancer. By targeting KRAS, a mutated protein previously considered undruggable, the treatment extends median patient survival to more than 13 months. This is a significant increase compared to the less than 7 months of survival typically achieved through standard chemotherapy alone. With pancreatic cancer claiming the lives of more than 50,000 Americans annually, this therapeutic milestone offers clinical practitioners a powerful new tool for a disease that has historically carried exceptionally grim prognoses.

In related medical developments, researchers at the University of California, San Francisco (UCSF) have mapped 100 proteins linked to severe autism alongside 1,000 interacting proteins. This mapping reveals how genetic mutations disrupt cellular partnerships, providing drug developers with precise biological targets that two decades of genetic research had failed to identify. Additionally, University College London (UCL) conducted a clinical trial of 35 patients using an experimental gene therapy called VERVE-102. The treatment permanently deactivates a specific liver gene, reducing harmful LDL cholesterol by 62 percent for up to a year without requiring daily medication.

Beyond healthcare, technological innovations are reshaping transport and climate management. MIT spinout Electra has secured 850 million dollars to scale production of its new hybrid aircraft in Ohio, aiming to manufacture 800 units annually. The aircraft utilizes eight electric motors and a gas generator to operate from spaces the size of a soccer field, boasting a 1,200-mile range and a 200 mph cruising speed for regional trips between 50 and 250 miles. Meanwhile, weather-modification startup Rainmaker deployed drones over the Kenai Peninsula to disperse silver iodide. The company estimates this cloud-seeding operation generated approximately 19 million gallons of precipitation within three hours, presenting a potential tool for drought mitigation in areas like the Colorado River basin.